Loading organizations...

§ Private Profile · Bremen, Bremen, Germany
SaaS platform developing an AI-driven, FHIR-based system to streamline clinical trial processes for researchers and healthcare professionals.
Founded in 2023 by Gustav Vella and Yannick Boerner, Bremen-based Carelane develops an AI-driven, FHIR-based SaaS platform that streamlines the entire clinical trial process from initial protocol authoring to final data collection. The company has secured approximately €3.4 million in total venture capital financing, including an €800,000 pre-seed investment and a subsequent €2.6 million seed round led by Vorwerk Ventures with participation from High-Tech Gründerfonds. Serving the healthcare and information technology sectors, the comprehensive system reduces technology costs for clinical researchers and is currently utilized by over 100 enrolled research sites. Having reached feature completeness for all trial stages, the platform provides workflow management and study design infrastructure for enterprise customers like the European Confederation of Medical Mycology. To support its ongoing commercial expansion, the organization recently appointed Brian Misher as its Chief Growth Officer.
Carelane has raised $850K across 1 funding round.
Carelane has raised $850K in total across 1 funding round.
Carelane has raised $850K across 1 funding round. Most recently, it raised $850K Pre-Seed in June 2024.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jun 27, 2024 | $850K Pre Seed | DR. Baltrukovich Natalya, Mba, PHD | — | Announced |
Carelane has raised $850K in total across 1 funding round.
Carelane's investors include Dr. Baltrukovich Natalya, MBA, PhD.